Prelude Capital Management’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-100
Closed -$2K 1577
2020
Q3
$2K Buy
+100
New +$2.12K ﹤0.01% 1670
2020
Q2
Sell
-300
Closed -$7K 2084
2020
Q1
$7K Sell
300
-100
-25% -$2.51K ﹤0.01% 1184
2019
Q4
$11K Buy
+400
New +$11K ﹤0.01% 1687
2019
Q1
Sell
-4,190
Closed -$101K 1943
2018
Q4
$101K Buy
+4,190
New +$109K 0.01% 928
2018
Q3
Sell
-3,973
Closed -$109K 1857
2018
Q2
$109K Buy
3,973
+1,053
+36% +$27.9K 0.01% 890
2018
Q1
$73K Sell
2,920
-2,511
-46% -$60.3K 0.01% 956
2017
Q4
$126K Buy
5,431
+3,831
+239% +$90.2K 0.01% 733
2017
Q3
$37K Buy
1,600
+1,100
+220% +$26.2K ﹤0.01% 1180
2017
Q2
$13K Buy
+500
New +$13.7K ﹤0.01% 1349

Other funds holding HSTM

Prelude Capital Management's HSTM Position: Q4 2020 in Review

Prelude Capital Management sold out of HealthStream (HSTM) in Q4 2020, closing a stake of 100 shares — an estimated $2K sold.

Prelude Capital Management first reported a position in HSTM in Q2 2017 and held it in 9 quarters. The position peaked at $126K in Q4 2017. 149 funds tracked by Wall St. Rank hold HSTM as of Q4 2020.

  • Prelude Capital Management reported no remaining HealthStream position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 100 HealthStream shares in Q4 2020, an estimated $2K.
  • Prelude Capital Management first reported a position in HealthStream in Q2 2017 and held it in 9 quarters.
  • Prelude Capital Management's HealthStream position peaked at $126K in Q4 2017.
  • 149 funds tracked by Wall St. Rank held HealthStream as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.